No Data
No Data
Innotek (688253.SH): First repurchase of 0.0259 million shares of the company's stock.
On September 6, 2024, Innotek (688253.SH) announced that the company repurchased 25,919 shares of the company for the first time through the trading system of the Shanghai Stock Exchange by centralized competitive trading, accounting for 0.0190% of the total share capital of 136,060,816 shares. The highest price for the repurchase transaction was 36.00 yuan/share, and the lowest price was 35.93 yuan/share. The total amount paid was 933,013.45 yuan (excluding stamp duty, trading commission, and other trading expenses).
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Innotek (688253.SH): The net income in the first half of the year was 0.206 billion yuan, with a year-on-year growth of 166.45%.
On August 29, Gelonhui announced its semi-annual report for 2024. During the reporting period, the revenue was 0.421 billion yuan, an 88.33% year-on-year increase; the net income attributable to shareholders of the listed company was 0.206 billion yuan, a 166.45% year-on-year increase; the net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.191 billion yuan, a 205.45% year-on-year increase; and the basic earnings per share was 1.52 yuan.
Innotek (688253.SH): plans to buy back shares for an amount between 50 million yuan and 0.1 billion yuan.
Innotek (688253.SH) announced that it plans to repurchase shares with an amount not less than CNY 50 million and not more than CNY 0.1 billion. The repurchase price of shares will not exceed CNY 50.00 per share. The shares repurchased this time will be used for the company's stock-based incentives and/or employee stock ownership plans at an appropriate time in the future, and will be transferred within 3 years after the announcement of the results of the share repurchase and share changes; if the company fails to transfer all repurchased shares within 3 years after the announcement of the results of the share repurchase and share changes, the unreleased repurchased shares will be cancelled. If the country makes adjustments to relevant policies, the repurchase will be subject to adjustment.
Innotek (688253.SH) has great confidence in the continuous development of its future business.
On July 30th, Gelonhui reported that Innotek (688253.SH) disclosed its investor relations activity records, which showed that the company will continue to expand the hospital coverage at the company level while continuing to work on admissions, further academic promotion and increasing product penetration. The company will also continue to introduce new products, and increase development in overseas and self-testing markets. The company has great confidence in the continuous development of its business in the future.
No Data
No Data